Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2114323 | Cancer Letters | 2009 | 9 Pages |
Abstract
The response of cancer patients to interferon (IFN) treatment is long-lasting, indicating that IFN may act on small cancer stem cell populations. Glioma-initiating cells (GICs) can self-renew and induce the formation of heterogeneously differentiated tumor cells and are resistant to chemotherapeutic agents like temozolomide. In this study, we showed that via STAT3 signaling, IFN-β suppressed the proliferation, self-renewal, and tumorigenesis of GICs, induced their terminal differentiation to mature oligodendroglia-like cells, and exhibited synergistic cytotoxicity with temozolomide. Therefore, IFN may be a potential therapeutic agent for inducing the terminal differentiation of GICs.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Kanako Yuki, Atsushi Natsume, Hidenori Yokoyama, Yutaka Kondo, Masasuke Ohno, Takenori Kato, Phassarin Chansakul, Motokazu Ito, Seung-Up Kim, Toshihiko Wakabayashi,